Try

EXACT SCIENCES CORPORATION

EXASUnited States

43 filed reports · 626 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

FigureLatest fiscal yearLatest quarter
Revenue$3.25BFY2025 · to Dec 31, 2025+17.7% from $2.76B10-K$851MQ3 FY2025 · to Sep 30, 2025+20.0% from $709M10-Q
Net income-$208MFY2025 · to Dec 31, 2025a year earlier: -$1.03B10-K-$19.6MQ3 FY2025 · to Sep 30, 2025a year earlier: -$38.2M10-Q
Operating income-$206MFY2025 · to Dec 31, 2025a year earlier: -$1.05B10-K-$25.5MQ3 FY2025 · to Sep 30, 2025a year earlier: -$39.4M10-Q

Filed reports

43 reports · Jun 2015 to Dec 2025

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR325,241Jun 2015 to Sep 2025
Annual · 10-KSEC EDGAR115,969Dec 2015 to Dec 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY202510-KDec 31, 2025Feb 13, 20261,091Open
FY2025 Q310-QSep 30, 2025Nov 3, 2025301Open
FY2025 Q210-QJun 30, 2025Aug 6, 2025250Open
FY2025 Q110-QMar 31, 2025May 1, 2025248Open
FY202410-KDec 31, 2024Feb 19, 2025576Open
FY2024 Q310-QSep 30, 2024Nov 5, 2024202Open
FY2024 Q210-QJun 30, 2024Jul 31, 2024160Open
FY2024 Q110-QMar 31, 2024May 8, 2024172Open
FY202310-KDec 31, 2023Feb 21, 2024517Open
FY2023 Q110-QSep 30, 2023Nov 1, 2023200Open
FY2023 Q110-QJun 30, 2023Aug 1, 2023160Open
FY2023 Q110-QMar 31, 2023May 9, 2023168Open

Financial data

626 concepts · 11,210 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial621 concepts · 11,096 facts · Dec 2012 to Dec 2025

  • Accumulated other comprehensive income loss net of tax63 · Dec 2012 to Dec 2025
  • Cash and cash equivalents at carrying value63 · Dec 2012 to Dec 2025
  • Allocated share based compensation expense61 · Dec 2013 to Dec 2025
  • General and administrative expense (US GAAP)61 · Dec 2013 to Dec 2025
  • Nonoperating income expense61 · Dec 2013 to Dec 2025
  • Operating income loss61 · Dec 2013 to Dec 2025
  • Research and development expense61 · Dec 2013 to Dec 2025
  • Selling and marketing expense (US GAAP)61 · Dec 2013 to Dec 2025
  • Stockholders equity (US GAAP)60 · Dec 2012 to Dec 2025
  • Antidilutive securities excluded from computation of earnings per share amount59 · Dec 2013 to Dec 2025
  • Increase decrease in accounts payable59 · Dec 2013 to Dec 2025
  • Inventory net59 · Jun 2014 to Dec 2025
  • Inventory raw materials and supplies59 · Jun 2014 to Dec 2025
  • Other comprehensive income loss net of tax portion attributable to parent59 · Dec 2013 to Dec 2025
  • Payments to acquire marketable securities59 · Dec 2013 to Dec 2025
  • Payments to acquire property plant and equipment59 · Dec 2013 to Dec 2025
  • Proceeds from sale and maturity of marketable securities59 · Dec 2013 to Dec 2025
  • Revenue59 · Dec 2013 to Dec 2025
  • Share based compensation59 · Dec 2013 to Dec 2025
  • Cost of revenue (US GAAP)58 · Sep 2014 to Dec 2025
  • Comprehensive income net of tax57 · Dec 2013 to Dec 2025
  • Increase decrease in inventories57 · Dec 2014 to Dec 2025
  • Noncash or part noncash acquisition fixed assets acquired157 · Dec 2013 to Dec 2025
  • Accounts payable current56 · Dec 2014 to Dec 2025

Geography1 concept · 62 facts · Dec 2017 to Dec 2025

  • Revenue62 · Dec 2017 to Dec 2025

Product4 concepts · 52 facts · Dec 2016 to Sep 2019

  • Revenue48 · Dec 2016 to Sep 2019
  • Cost of goods and services sold (US GAAP)2 · Dec 2018
  • Contribution to Construction Project1 · Dec 2018
  • Contribution to Construction Project By Owner1 · Dec 2018

Segments

114 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement geographical2 members · 62 facts

  • Outside of United States31 · Dec 2017 to Dec 2025
  • United States31 · Dec 2017 to Dec 2025

Product or servicesrt:ProductOrServiceAxis4 members · 40 facts

  • Commercial12 · Dec 2016 to Sep 2019
  • Medicare Parts B & C12 · Dec 2016 to Sep 2019
  • Other12 · Dec 2016 to Sep 2019
  • Construction project4 · Dec 2018

Product or serviceus-gaap:ProductOrServiceAxis3 members · 12 facts

  • Commercial4 · Mar 2017 to Jun 2018
  • Medicare Parts B & C4 · Mar 2017 to Jun 2018
  • Other4 · Mar 2017 to Jun 2018

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of EXACT SCIENCES CORPORATION (EXAS) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 16, 2026) and refreshed every few hours.

EXACT SCIENCES CORPORATION (EXAS): FY2025 revenue $3.25B · FactIQ